Viatris(VTRS)
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Cardura | Doxazosin | 1990-11-02 | ||
| Clopidogrel viatris (previously clopidogrel taw pharma) | Clopidogrel | 2009-10-16 | ||
| Dilantin | Phenytoin | 1982-01-01 | ||
| Geodon | Ziprasidone | 2001-02-05 | ||
| Mysildecard | Sildenafil | 2016-09-15 | 2038 | |
| Neurontin | Gabapentin | 1993-12-30 | 2024 | |
| Nitrostat | Nitroglycerin | 2000-05-01 | 2029-2032 | |
| Norvasc | Amlodipine besylate | 1992-07-31 | — | |
| Revatio | Sildenafil | 2005-06-03 | 2038 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use